Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants accelerated approval to Amondys 45 for Duchenne muscular dystrophy

Feb. 26, 2021

Pilot trial of lentivirus-mediated enzyme gene therapy for the treatment of Fabry disease

Feb. 26, 2021

Targeting EPIC1-EZH2 axis as potential new immunotherapy strategy in cancer

Feb. 26, 2021

First patient dosed in phase I/II study of KB-0742

Feb. 26, 2021

Chromosome organization machinery linked to DNA repair

Feb. 26, 2021

Compugen presents updated results from phase I study of COM-701

Feb. 26, 2021

MicroRNA switch therapy self-assembles into nanoparticles to treat atherosclerosis

Feb. 26, 2021

Italian researchers present new PTPN11 inhibitors

Feb. 26, 2021

Amgen discovers new KIF18A inhibitors

Feb. 26, 2021

First patient dosed in phase III study of eftansomatropin alfa in China

Feb. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...